Editorial Commentary
The sooner, the better: early clearance of plasma circulating tumor DNA in patients with advanced KRAS G12C mutant non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(2)
:215-219
.
(29 February 2024)
What the future holds: BBT-176, beyond third-generation EGFR tyrosine kinase inhibitors
Translational Lung Cancer Research
2024;
13
(2)
:220-222
.
(29 February 2024)
Determinants of Aurora kinase B inhibitor sensitivity in small cell lung cancer
Translational Lung Cancer Research
2024;
13
(2)
:223-228
.
(29 February 2024)
Dual immuno-oncology agents as neoadjuvant therapy for patients with resectable non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(2)
:229-235
.
(29 February 2024)
High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers
Translational Lung Cancer Research
2024;
13
(2)
:236-239
.
(29 February 2024)
Original Article
“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders
Translational Lung Cancer Research
2024;
13
(2)
:240-255
.
(29 February 2024)
The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity
Translational Lung Cancer Research
2024;
13
(2)
:256-268
.
(29 February 2024)
Intracranial response pattern, tolerability and biomarkers associated with brain metastases in non-small cell lung cancer treated by tislelizumab plus chemotherapy
Translational Lung Cancer Research
2024;
13
(2)
:269-279
.
(29 February 2024)
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses
Translational Lung Cancer Research
2024;
13
(2)
:280-291
.
(29 February 2024)
Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer
Translational Lung Cancer Research
2024;
13
(2)
:292-306
.
(29 February 2024)
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Translational Lung Cancer Research
2024;
13
(2)
:307-320
.
(29 February 2024)
HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors
Translational Lung Cancer Research
2024;
13
(2)
:321-333
.
(29 February 2024)
Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer Database
Translational Lung Cancer Research
2024;
13
(2)
:334-344
.
(29 February 2024)
PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(2)
:345-354
.
(29 February 2024)
Brief Report
Fibre-based fluorescence-lifetime imaging microscopy: a real-time biopsy guidance tool for suspected lung cancer
Translational Lung Cancer Research
2024;
13
(2)
:355-361
.
(29 February 2024)
Review Article
Survivin in lung cancer: a potential target for therapy and prevention—a narrative review
Translational Lung Cancer Research
2024;
13
(2)
:362-374
.
(29 February 2024)
Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review
Translational Lung Cancer Research
2024;
13
(2)
:375-397
.
(29 February 2024)
Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review
Translational Lung Cancer Research
2024;
13
(2)
:398-422
.
(29 February 2024)
Case Report: iMDT Corner
Single-port video-assisted thoracoscopic sleeve lobectomy after neoadjuvant immunochemotherapy: a case report
Translational Lung Cancer Research
2024;
13
(2)
:423-433
.
(29 February 2024)
Case Report
Osimertinib in uncommon EGFR exon 21 L861R and EGFR exon 18 deletion-insertion mutant non-small cell lung cancer—case report
Translational Lung Cancer Research
2024;
13
(2)
:434-442
.
(29 February 2024)
Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review
Translational Lung Cancer Research
2024;
13
(2)
:443-452
.
(29 February 2024)
